|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jung KW, Won YJ, Kong HJ, Lee ES and
Community of Population-Based Regional Cancer Registries: Cancer
statistics in korea: Incidence, mortality, survival, and prevalence
in 2015. Cancer Res Treat. 50:303–316. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ahn HS, Lee HJ, Yoo MW, Jeong SH, Park DJ,
Kim HH, Kim WH, Lee KU and Yang HK: Changes in clinicopathological
features and survival after gastrectomy for gastric cancer over a
20-year period. Br J Surg. 98:255–260. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
GASTRIC (Global Advanced/Adjuvant Stomach
Tumor Research International Collaboration) Group, ; Oba K,
Paoletti X, Bang YJ, Bleiberg H, Burzykowski T, Fuse N, Michiels S,
Morita S, Ohashi Y, et al: Role of chemotherapy for
advanced/recurrent gastric cancer: An individual-patient-data
meta-analysis. Eur J Cancer. 49:1565–1577. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanat O, O'Neil B and Shahda S: Targeted
therapy for advanced gastric cancer: A review of current status and
future prospects. World J Gastrointest Oncol. 7:401–410. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuan DD, Zhu ZX, Zhang X and Liu J:
Targeted therapy for gastric cancer: Current status and future
directions (Review). Oncol Rep. 35:1245–1254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jain D, Nemec S, Luxey M, Gauthier Y,
Bemmo A, Balsalobre A and Drouin J: Regulatory integration of Hox
factor activity with T-box factors in limb development.
Development. 145:1598302018. View Article : Google Scholar
|
|
8
|
Gabellini D, Colaluca IN, Vodermaier HC,
Biamonti G, Giacca M, Falaschi A, Riva S and Peverali FA: Early
mitotic degradation of the homeoprotein HOXC10 is potentially
linked to cell cycle progression. EMBO J. 22:3715–3724. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ng Y, Tan SX, Chia SY, Tan HY, Gun SY, Sun
L, Hong W and Han W: HOXC10 suppresses browning of white adipose
tissues. Exp Mol Med. 49:e2922017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng X, Li T, Liu Z, Shi Y and Peng Y:
HOXC10 up-regulation contributes to human thyroid cancer and
indicates poor survival outcome. Mol Biosyst. 11:2946–2954. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang XL, Ding BX, Hua Y, Chen H, Wu T,
Chen ZQ and Yuan CH: HOXC10 Promotes the metastasis of human lung
adenocarcinoma and indicates poor survival outcome. Front Physiol.
8:5572017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li S, Zhang W, Wu C, Gao H, Yu J, Wang X,
Li B, Jun Z, Zhang W, Zhou P, et al: HOXC10 promotes proliferation
and invasion and induces immunosuppressive gene expression in
glioma. FEBS J. 285:2278–2291. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie X, Xiao Y and Huang X: Homeobox C10
knockdown suppresses cell proliferation and promotes cell apoptosis
in osteosarcoma cells through regulating caspase 3. Onco Targets
Ther. 11:473–482. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ansari KI, Hussain I, Kasiri S and Mandal
SS: HOXC10 is overexpressed in breast cancer and transcriptionally
regulated by estrogen via involvement of histone methylases MLL3
and MLL4. J Mol Endocrinol. 48:61–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pathiraja TN, Nayak SR, Xi Y, Jiang S,
Garee JP, Edwards DP, Lee AV, Chen J, Shea MJ, Santen RJ, et al:
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast
cancer. Sci Transl Med. 6:229ra2412014. View Article : Google Scholar
|
|
16
|
Sadik H, Korangath P, Nguyen NK, Gyorffy
B, Kumar R, Hedayati M, Teo WW, Park S, Panday H, Munoz TG, et al:
HOXC10 expression supports the development of chemotherapy
resistance by fine tuning DNA repair in breast cancer cells. Cancer
Res. 76:4443–4456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jones PA: Functions of DNA methylation:
Islands, start sites, gene bodies and beyond. Nat Rev Genet.
13:484–492. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo C, Hou J, Ao S, Deng X and Lyu G:
HOXC10 up-regulation promotes gastric cancer cell proliferation and
metastasis through MAPK pathway. Chin J Cancer Res. 29:572–580.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yao S, He L, Zhang Y, Ye L, Lai Y, Huang
L, Wu L, Wu G and Zhu S: HOXC10 promotes gastric cancer cell
invasion and migration via regulation of the NF-κB pathway. Biochem
Biophys Res Commun. 501:628–635. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee J, Sohn I, Do IG, Kim KM, Park SH,
Park JO, Park YS, Lim HY, Sohn TS, Bae JM, et al: Nanostring-based
multigene assay to predict recurrence for gastric cancer patients
after surgery. PLoS One. 9:e901332014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dobin A, Davis CA, Schlesinger F, Drenkow
J, Zaleski C, Jha S, Batut P, Chaisson M and Gingeras TR: STAR:
Ultrafast universal RNA-seq aligner. Bioinformatics. 29:15–21.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng J, Ge P, Liu X, Wei J, Wu G and Li
X: MiR-136 inhibits gastric cancer-specific peritoneal metastasis
by targeting HOXC10. Tumour Biol. 39:10104283177062072017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi EH, Kim JT, Kim JH, Kim SY, Song EY,
Kim JW, Kim SY, Yeom YI, Kim IH and Lee HG: Upregulation of the
cysteine protease inhibitor, cystatin SN, contributes to cell
proliferation and cathepsin inhibition in gastric cancer. Clin Chim
Acta. 406:45–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ge F, Wang C, Wang W and Wu B: S100P
predicts prognosis and drug resistance in gastric cancer. Int J
Biol Markers. 28:e387–392. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Q, Hu H, Shi X and Tang W: Knockdown
of S100P by lentiviral-mediated RNAi promotes apoptosis and
suppresses the colony-formation ability of gastric cancer cells.
Oncol Rep. 31:2344–2350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Chen Y, Wang X, Zhang H, Zhang Y,
Gao Y, Weng M, Wang L, Liang H, Li M, et al: LASP-1 induces
proliferation, metastasis and cell cycle arrest at the G2/M phase
in gallbladder cancer by down-regulating S100P via the PI3K/AKT
pathway. Cancer Lett. 372:239–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu TS, Tan CT, Chang CC, Lin BR, Lai WT,
Chen ST, Yen-Ping Kuo M, Rau CL, Jaw FS and Chang HH: B-cell
lymphoma/leukemia 10 promotes oral cancer progression through
STAT1/ATF4/S100P signaling pathway. Oncogene. 36:54402017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao X, Li Y, Luo RZ, Zhang L, Zhang SL,
Zeng J, Han YJ and Wen ZS: Expression of cystatin SN significantly
correlates with recurrence, metastasis, and survival duration in
surgically resected non-small cell lung cancer patients. Sci Rep.
5:82302015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dai DN, Li Y, Chen B, Du Y, Li SB, Lu SX,
Zhao ZP, Zhou AJ, Xue N, Xia TL, et al: Elevated expression of CST1
promotes breast cancer progression and predicts a poor prognosis. J
Mol Med (Berl). 95:873–886. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang J, Liu HL, Liu ZH, Tan SW and Wu B:
Identification of cystatin SN as a novel biomarker for pancreatic
cancer. Tumour Biol. 36:3903–3910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim JT, Lee SJ, Kang MA, Park JE, Kim BY,
Yoon DY, Yang Y, Lee CH, Yeom YI, Choe YK and Lee HG: Cystatin SN
neutralizes the inhibitory effect of cystatin C on cathepsin B
activity. Cell Death Dis. 4:e9742013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miwa T, Kanda M, Umeda S, Tanaka H, Tanaka
C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, et al:
Homeobox C10 influences on the malignant phenotype of gastric
cancer cell lines and its elevated expression positively correlates
with recurrence and poor survival. Ann Surg Oncol. 26:1535–1543.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin B, Xue Y, Qi C, Chen X and Mao W:
Expression of transmembrane protein 41A is associated with
metastasis via the modulation of ecadherin in radically resected
gastric cancer. Mol Med Rep. 18:2963–2972. 2018.PubMed/NCBI
|
|
36
|
Rezsohazy R: Non-transcriptional
interactions of hox proteins: Inventory, facts, and future
directions. Dev Dyn. 243:117–131. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oh SS, Park S, Lee KW, Madhi H, Park SG,
Lee HG, Cho YY, Yoo J and Dong Kim K: Extracellular cystatin SN and
cathepsin B prevent cellular senescence by inhibiting abnormal
glycogen accumulation. Cell Death Dis. 8:e27292017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Blanco MA, LeRoy G, Khan Z, Alečković M,
Zee BM, Garcia BA and Kang Y: Global secretome analysis identifies
novel mediators of bone metastasis. Cell Res. 22:1339–1355. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cai X, Luo J, Yang X, Deng H, Zhang J, Li
S, Wei H, Yang C, Xu L, Jin R, et al: In vivo selection for
spine-derived highly metastatic lung cancer cells is associated
with increased migration, inflammation and decreased adhesion.
Oncotarget. 6:22905–22917. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu XF, Xiang L, Zhang Y, Becker KG, Bera
TK and Pastan I: CAPC negatively regulates NF-κB activation and
suppresses tumor growth and metastasis. Oncogene. 31:1673–1682.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang J, Liu HL, Tao L, Lin XY, Yang YD,
Tan SW and Wu B: Let7d inhibits colorectal cancer cell
proliferation through the CST1/p65 pathway. Int J Oncol.
53:781–790. 2018.PubMed/NCBI
|
